Evoke Pharma Inc. (EVOK) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Evoke Pharma Inc.

    NASDAQ: EVOK · Real-Time Price · USD
    4.57
    -0.04 (-0.87%)
    At close: Oct 03, 2025, 3:59 PM
    4.61
    0.85%
    After-hours: Oct 03, 2025, 07:33 PM EDT

    Evoke Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10.25M 5.18M 2.51M 1.62M
    Cost of Revenue
    		 356.53K 201.88K 370.39K 328.12K
    Gross Profit
    		 9.89M 4.98M 2.14M 1.29M
    Operating Income
    		 -5.2M -7.43M -7.79M -8.15M
    Interest Income
    		 353.31K 138.6K 62.01K 8.62K
    Pretax Income
    		 -5.35M -7.79M -8.22M -8.54M
    Net Income
    		 -5.35M -7.79M -8.16M -9.03M
    Selling & General & Admin
    		 15.08M 12.23M 9.62M 8.85M
    Research & Development
    		 16.32K 181.91K 300.79K 590.48K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 15.1M 12.41M 9.92M 9.44M
    Interest Expense
    		 501.37K 500K 500K 500.05K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 15.45M 12.61M 10.29M 9.77M
    Income Tax Expense
    		 n/a n/a -62.01K 491.44K
    Shares Outstanding (Basic)
    		 1.91M 278.56K 261.97K 223.51K
    Shares Outstanding (Diluted)
    		 1.91M 278.56K 261.97K 223.51K
    EPS (Basic)
    		 -2.81 -27.97 -31.16 -40.4
    EPS (Diluted)
    		 -2.81 -27.97 -31.16 -40.4
    EBITDA
    		 -4.85M -7.29M -7.72M -8.04M
    EBIT
    		 -4.85M -7.29M -7.72M -8.04M
    Depreciation & Amortization
    		 5.2M 138.6K 7.79M 8.15M

    Add to Watchlist